Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells
β Scribed by Mei-Jen Chuang; Kuang-Hui Sun; Shye-Jye Tang; Ming-Wei Deng; Yu-Hsin Wu; Jung-Sung Sung; Tai-Lung Cha; Guang-Huan Sun
- Book ID
- 108584148
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 362 KB
- Volume
- 99
- Category
- Article
- ISSN
- 1347-9032
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Whereas cytokine therapy has proven efficacy in the treatment of metastatic renal cell carcinoma (RCC), many questions regarding the use of these drugs remain unanswered. In the present study we evaluated the antiproliferative effects of human recombinant alpha-interferon (IFN), gamma-interferon and
## Abstract Constitutive activation of the MAP kinase kinase MEK1 induces oncogenic transformation in intestinal epithelial cells. Loss of cellβcell adhesion followed by the dissociation of epithelial structures is a prerequisite for increased cell motility and tumor invasion. This phenotypic switc
Because renal-cell carcinoma (RCC) is considered relatively resistant to radio-and chemotherapy, RCC patients may benefit from new treatment modalities, e.g. immunotherapy. In vitro and in vivo studies suggest that combinations of cytokines such as interferon y or interferon a (IFN-y, IFN-a) and tum